Lenzilumab
Product Specifications
CAS Number
1229575-09-0
Target
C-Fms, SARS-CoV
Related Pathways
Microbiology/Virology, Tyrosine Kinase/Adaptors
Purity
0.989
Bioactivity
Lenzilumab (KB 003) is a humanized granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibody that directly binds to GM-CSF and prevents signaling through its receptor, and can be used to study COVID-19.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740669-500 1x 500 µL
P27 / KIP1 (SX53G8), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472559-100 1x 100 µL
Human IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker) (IGHM/2559R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details